Pitch deck

Svastia's pitch deck

We hold this deck but have observed no funding round for this company. That is a gap in our record rather than a statement about the company.

Svastia Genetics, operating under the Svastia.ai brand, is a clinical-genomic and precision oncology company dedicated to enhancing cancer therapy outcomes through personalized genetic screening and decision support. The company provides a genomics-driven platform tailored for healthcare, pharmaceutical, and biotechnology users, with offices in San Francisco and Cambridge. Svastia's platform assists clinicians, researchers, and drug developers in utilizing patient genetic data to optimize cancer treatment selection and predict relapse. The company offers a range of services, including clinical decision support, oncology knowledgebase-driven analytics, and comprehensive genomic workflows. Its products include clinical-genomic screening for cancer patients, research-use-only diagnostic reporting, DNA/RNA sequencing, and tools for therapeutic-antibody development. Svastia serves a diverse clientele, including hospitals, diagnostics labs, researchers, and pharmaceutical R&D customers.

Read the deckFree account. The deck belongs to Svastia, so reading it needs one; everything on this page is public.